Perinatal deaths after sildenafil treatment of fetal growth restriction raise the issue of safety in randomised clinical trials.
Niccolò LombardiGiada CrescioliAlessandra BettiolClaudia RavaldiNiccolò LombardiPublished in: Pharmacoepidemiology and drug safety (2019)